Figure 3.

Therapeutic efficacy of Dasatinib for the treatment of HCC developed in c‐Myc mice. A, Study design. B, Liver weight comparison in pre‐treated (n = 9), vehicle (n = 9), and Dasatinib treated (n = 9) FVB/N mice. (C) Liver/body weight comparison in pre‐treated(n = 9), vehicle(n = 9), and Dasatinib treated (n = 9) FVB/N mice. Data are presented as mean ± SD; and P‐value was calculated using Mann‐Whitney U test. Each dot represents one value for one mouse. Das, Dasatinib; Pre, Pre‐treatment; Veh, Vehicle